Immuron Limited - Warrants (12/05/2022) Operating Income

As of the most recent data (June 2026), IMRNW shows a operating income of $-7.6M. That compares with $-11M in the prior-year period — up 31.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, IMRNW's operating income is now $-7.6M (was $-11M) — a 31.8% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Immuron Limited - Warrants (12/05/2022) is outperforming or lagging.

Tracking IMRNW's operating income over time shows whether Immuron Limited - Warrants (12/05/2022) is scaling, shrinking, or reshaping that part of the business. The current reading is $-7.6M That compares with $-11M in the prior-year period — up 31.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this operating income page, Stockcircle has Immuron Limited - Warrants (12/05/2022)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect operating income (currently $-7.6M) with ownership activity and broader fundamentals.

Immuron Limited - Warrants (12/05/2022)'s operating income is $-7.6M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.